-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Tandem Diabetes Care Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2018 to Q2 2024.
- Tandem Diabetes Care Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $1.07M, a 6.55% decline year-over-year.
- Tandem Diabetes Care Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $5.18M, a 85.5% increase year-over-year.
- Tandem Diabetes Care Inc annual Income Tax Expense (Benefit) for 2023 was $2.36M, a 35.3% increase from 2022.
- Tandem Diabetes Care Inc annual Income Tax Expense (Benefit) for 2022 was $1.74M, a 420% increase from 2021.
- Tandem Diabetes Care Inc annual Income Tax Expense (Benefit) for 2021 was $335K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)